These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25224482)

  • 1. Cancer- and treatment-related cognitive changes: what can we do now? What lies ahead?
    Bender CM; Merriman JD
    Oncology (Williston Park); 2014 Sep; 28(9):806-8. PubMed ID: 25224482
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer treatment and cognitive function: chemotherapy is not the only culprit.
    Ganz PA
    Oncology (Williston Park); 2014 Sep; 28(9):804-6. PubMed ID: 25224481
    [No Abstract]   [Full Text] [Related]  

  • 3. An overview of chemotherapy-related cognitive dysfunction, or 'chemobrain'.
    Moore HC
    Oncology (Williston Park); 2014 Sep; 28(9):797-804. PubMed ID: 25224480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemobrain: is it time to initiate guidelines for assessment and management?
    Patel SK; Hurria A; Mandelblatt JS
    Oncology (Williston Park); 2014 Sep; 28(9):809-10. PubMed ID: 25224483
    [No Abstract]   [Full Text] [Related]  

  • 5. Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments.
    McAllister TW; Ahles TA; Saykin AJ; Ferguson RJ; McDonald BC; Lewis LD; Flashman LA; Rhodes CH
    Curr Psychiatry Rep; 2004 Oct; 6(5):364-71. PubMed ID: 15355759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive dysfunction following adjuvant treatment of breast cancer: a new dose-limiting toxic effect?
    Ganz PA
    J Natl Cancer Inst; 1998 Feb; 90(3):182-3. PubMed ID: 9462670
    [No Abstract]   [Full Text] [Related]  

  • 7. Cognitive deficits are usually mild in patients with breast cancer after chemotherapy.
    Barton MK
    CA Cancer J Clin; 2013 Jan; 63(1):3-4. PubMed ID: 23169539
    [No Abstract]   [Full Text] [Related]  

  • 8. Cognitive problems after chemotherapy for breast cancer.
    Harv Womens Health Watch; 2002 Oct; 10(2):5-6. PubMed ID: 12393318
    [No Abstract]   [Full Text] [Related]  

  • 9. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Results of a prospective, randomized, longitudinal trial.
    Maruff P; Falleti MG; Collie A
    Cancer; 2004 Nov; 101(9):2143-4; author reply 2144-5. PubMed ID: 15382092
    [No Abstract]   [Full Text] [Related]  

  • 10. Imaging Brain Networks After Cancer and Chemotherapy: Advances Toward Etiology and Unanswered Questions.
    Nudelman KN; McDonald BC; Saykin AJ
    JAMA Oncol; 2016 Feb; 2(2):174-6. PubMed ID: 26633755
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy-induced cognitive impairment in women with breast cancer: a critique of the literature.
    Jansen CE; Miaskowski C; Dodd M; Dowling G
    Oncol Nurs Forum; 2005 Mar; 32(2):329-42. PubMed ID: 15759070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
    Schagen SB; van Dam FS
    J Clin Oncol; 2006 Nov; 24(32):5170-1; author reply 5171-2. PubMed ID: 17093282
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
    Hermelink K
    Cancer; 2011 Mar; 117(5):1103; author reply 1103-4. PubMed ID: 20960507
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
    Wefel JS; Saleeba AK; Buzdar AU; Meyers CA
    Cancer; 2010 Jul; 116(14):3348-56. PubMed ID: 20564075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive speed of processing and functional declines in older cancer survivors: an analysis of data from the ACTIVE trial.
    Kvale EA; Clay OJ; Ross-Meadows LA; McGee JS; Edwards JD; Unverzagt FW; Ritchie CS; Ball KK
    Eur J Cancer Care (Engl); 2010 Jan; 19(1):110-7. PubMed ID: 19709169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study.
    Biglia N; Bounous VE; Malabaila A; Palmisano D; Torta DM; D'Alonzo M; Sismondi P; Torta R
    Eur J Cancer Care (Engl); 2012 Jul; 21(4):485-92. PubMed ID: 22211832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-related cognitive dysfunction in breast cancer.
    O'Shaughnessy J
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 2):17-24. PubMed ID: 14702917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulating evidence for the effect of chemotherapy on cognition.
    Rodin G; Ahles TA
    J Clin Oncol; 2012 Oct; 30(29):3568-9. PubMed ID: 22927529
    [No Abstract]   [Full Text] [Related]  

  • 19. Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study.
    Hermelink K; Küchenhoff H; Untch M; Bauerfeind I; Lux MP; Bühner M; Manitz J; Fensterer V; Münzel K
    Psychooncology; 2010 Dec; 19(12):1321-8. PubMed ID: 20127909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.
    Shilling V; Jenkins V; Morris R; Deutsch G; Bloomfield D
    Breast; 2005 Apr; 14(2):142-50. PubMed ID: 15767184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.